Editorial: Functional autoantibodies cause hypoparathyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 12, 2009, Pages 4655-4657

  Husebye, Eystein S ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; AUTOANTIBODY; AUTOIMMUNE REGULATOR PROTEIN; CALCIUM SENSING RECEPTOR; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); NACHT LEUCINE RICH PROTEIN 5; PROTEIN; STEROID 17ALPHA MONOOXYGENASE; STEROID 21 MONOOXYGENASE; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; AUTOANTIGEN; NALP5 PROTEIN, HUMAN;

ANTIBODY TITER; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CLINICAL FEATURE; EDITORIAL; GENE EXPRESSION; GENE MUTATION; HUMAN; IDIOPATHIC HYPOPARATHYROIDISM; IMMUNOPATHOGENESIS; MOLECULAR MECHANICS; PRIORITY JOURNAL; T LYMPHOCYTE; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY; GENETICS; HYPOPARATHYROIDISM; IMMUNOLOGY; NOTE; PHYSIOLOGY;

AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; HUMANS; HYPOPARATHYROIDISM; POLYENDOCRINOPATHIES, AUTOIMMUNE; RECEPTORS, CALCIUM-SENSING;

EID: 73249139163     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2123     Document Type: Editorial

References (27)

1. Shoback D 2008 Clinical practice. Hypoparathyroidism. N Engl J Med 359:391-403
2. Kobrynski LJ, Sullivan KE 2007 Velocardiofacial syndrome, Di-George syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 370:1443-1452
3. 2+-sensing receptor gene mutation. Nat Genet 8:303-307
4. Kifor O, McElduff A, LeBoff MS, Moore Jr FD, Butters R, Gao P, Cantor TL, Kifor I, Brown EM 2004 Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism. J Clin Endocrinol Metab 89:548-556
5. Perheentupa J 2006 Autoimmune polyendocrinopathy-candidiasis- ectodermal dystrophy. J Clin Endocrinol Metab 91:2843-2850
6. Husebye ES, Perheentupa J, Rautemaa R, Kämpe O 2009 Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Intern Med 265:514-529
7. Alimohammadi M, Björklund P, Hallgren A, Pöntynen N, Szinnai G, Shikama N, Keller MP, Ekwall O, Kinkel SA, Husebye ES, Gustafsson J, Rorsman F, Peltonen L, Betterle C, Perheentupa J, Akerström G, Westin G, Scott HS, Holländer GA, Kämpe O 2008 Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med 358:1018-1028
8. Kemp EH, Gavalas NG, Krohn KJE, Brown EM, Watson PF, Weetman AP 2009 Activating autoantibodies against the calcium-sensing receptor detected in two patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metabol 94:4749-4756
9. The Finnish-German APECED Consortium. Autoimmune Polyendocrinopathy- Candidiasis-Ectodermal Dystrophy 1997 An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 17:399-403
10. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D 2002 Projection of an immunological self shadow within the thymus by the aire protein. Science 298:1395-1401
11. Mathis D, Benoist C 2009 Aire. Annu Rev Immunol 27:287-312
12. Meager A, Visvalingam K, Peterson P, Möll K, Murumägi A, Krohn K, Eskelin P, Perheentupa J, Husebye E, Kadota Y, Willcox N 2006 Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 3:e289
13. Zhang L, Barker JM, Babu S, Su M, Stenerson M, Cheng M, Shum A, Zamir E, Badolato R, Law A, Eisenbarth GS, Anderson MS 2007 A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1. Clin Immunol 125:131-137
14. Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kämpe O 1993 Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J Clin Invest 92:2377-2385
15. Krohn K, Uibo R, Aavik E, Peterson P, Savilahti K 1992 Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17α-hydroxylase. Lancet 339:770-773
16. Uibo R, Aavik E, Peterson P, Perheentupa J, Aranko S, Pelkonen R, Krohn KJ 1994 Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. J Clin Endocrinol Metab 78:323-328
17. Ekwall O, Hedstrand H, Grimelius L, Haavik J, Perheentupa J, Gustafsson J, Husebye E, Kämpe O, Rorsman F 1998 Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 352:279-283
18. Hedstrand H, Ekwall O, Haavik J, Landgren E, Betterle C, Perheentupa J, Gustafsson J, Husebye E, Rorsman F, Kämpe O 2000 Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I. Biochem Biophys Res Commun 267:456-461
19. Rorsman F, Husebye ES, Winqvist O, Björk E, Karlsson FA, Kämpe O 1995 Aromatic-L-amino-acid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a β-cell autoantigen. Proc Natl Acad Sci USA 92:8626-8629
20. Söderbergh A, Myhre AG, Ekwall O, Gebre-Medhin G, Hedstrand H, Landgren E, Miettinen A, Eskelin P, Halonen M, Tuomi T, Gustafsson J, Husebye ES, Perheentupa J, Gylling M, Manns MP, Rorsman F, Kämpe O, Nilsson T 2004 Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 89:557-562
21. 2+-sensing receptor from bovine parathyroid. Nature 366:575-580
22. Li Y, Song YH, Rais N, Connor E, Schatz D, Muir A, Maclaren N 1996 Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 97:910-914
23. Gavalas NG, Kemp EH, Krohn KJ, Brown EM, Watson PF, Weetman AP 2007 The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 92:2107-2114
24. Tong Z-B, Nelson LM 1999 A mouse gene encoding an oocyte antigen associated with autoimmune premature ovarian failure. Endocrinology 140:3720-3726
25. Kifor O, Moore Jr FD, Delaney M, Garber J, Hendy GN, Butters R, Gao P, Cantor TL, Kifor I, Brown EM, Wysolmerski J 2003 A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor. J Clin Endocrinol Metab 88:60-72
26. Egbuna OI, Brown EM 2008 Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Pract Res Clin Rheumatol 22:129-148
27. Kendall-Taylor P, Lambert A, Mitchell R, Robertson WR 1988 Antibody that blocks stimulation of cortisol secretion by adrenocorticotrophic hormone in Addison's disease. Br Med J (Clin Res Ed) 296:1489-1491